Effect of stimulant medication on driving performance of young adults with attention-deficit hyperactivity disorder (ADHD) : a preliminary double-blind placebo controlled trial.

Author(s)
Cox, D.J. Merkel, R.L. Kovatchev, B. & Seward, R.
Year
Abstract

Driving performance of adult males with attention-deficit hyperactivity disorder (ADHD) was compared to matched controls in a double blind (Ritalin versus placebo), cross-over design, using a high fidelity simulator. Seven ADHD and six non-ADHD drivers (mean age 22 years) were screened to rule out comorbidity and assess for ADHD, and then admitted to the General Clinical Research Center to control diet and sleep before testing. At 0800 and 1530, subjects consumed either a placebo or Ritalin pill in a counter balanced manner, and at 0930 and 1700 subjects drove the simulator. Following both drives, subjects rated their driving performance. Compared to non-ADHD subjects, ADHD subjects had more career driving accidents (p<.04) and motor vehicle violations (p=.059), drove worse on the simulator under placebo condition (p<.05), demonstrated significant improvement under the Ritalin condition (p<.05), rated themselves as driving poorer during the placebo condition (p=.05), and tended to perceive their driving to be better during the Ritalin condition (p=.07). This would suggest that individuals with ADHD should have the therapeutic benefit of a stimulant medication when operating a vehicle. (A)

Request publication

8 + 12 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.

Publication

Library number
20001010 ST [electronic version only]
Source

Journal of Nervous and Mental Disease, Vol. 188 (2000), No. 4, p. 230-234, 22 ref.

Our collection

This publication is one of our other publications, and part of our extensive collection of road safety literature, that also includes the SWOV publications.